Intravenous immunoglobulin home treatment for patients with primary immunodeficiency diseases

7th International Immunoglobulin Conference: Immunodeficiencies.

Clinical and experimental immunology·2014

7th International Immunoglobulin Conference: Immunodeficiencies.

Clinical and experimental immunology·2014

Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies.

Clinical and experimental immunology·2011

Subcutaneous immunoglobulin: opportunities and outlook.

Clinical and experimental immunology·2009

Immunodeficiencies.

Clinical and experimental immunology·2009

Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Sex- and age-specific incidence and fraction of hospital contacts for infectious mononucleosis cases in Denmark in 1977-2011.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Research on the role and mechanism of SLC7A5 in idiopathic pulmonary fibrosis.

Molecular medicine reports·2026

Efficacy of IgY on Helicobacter pylori eradication and improvement of clinical symptoms: a randomized double-blind clinical trial.

Antibody therapeutics·2026

Correction: Unveiling the inflammatory link: integrated analysis identifies BMP7 and PPBP as key genes in obstructive sleep apnea-related atrial fibrillation.

Frontiers in cell and developmental biology·2026

A novel stop-loss variant in ISG15 causes C-terminal dysfunction and impairs USP18-mediated negative feedback.

Frontiers in immunology·2026

Evaluating the efficacy of intensified insulin therapy in hypertriglyceridemic acute pancreatitis management: a systematic review and meta-analysis.

Frontiers in medicine·2026

Related Experiment Videos

Intravenous immunoglobulin home treatment for patients with primary immunodeficiency diseases

Related Concept Videos

7th International Immunoglobulin Conference: Immunodeficiencies.

7th International Immunoglobulin Conference: Immunodeficiencies.

Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies.

Subcutaneous immunoglobulin: opportunities and outlook.

Immunodeficiencies.

Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantation.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Sex- and age-specific incidence and fraction of hospital contacts for infectious mononucleosis cases in Denmark in 1977-2011.

Research on the role and mechanism of SLC7A5 in idiopathic pulmonary fibrosis.

Efficacy of IgY on Helicobacter pylori eradication and improvement of clinical symptoms: a randomized double-blind clinical trial.

Correction: Unveiling the inflammatory link: integrated analysis identifies BMP7 and PPBP as key genes in obstructive sleep apnea-related atrial fibrillation.

A novel stop-loss variant in ISG15 causes C-terminal dysfunction and impairs USP18-mediated negative feedback.

Evaluating the efficacy of intensified insulin therapy in hypertriglyceridemic acute pancreatitis management: a systematic review and meta-analysis.

Related Experiment Videos

Intravenous immunoglobulin home treatment for patients with primary immunodeficiency diseases

Related Concept Videos

Related Articles